Sales decline 0.98% to Rs 98.32 crore
Net loss of Novartis India reported to Rs 23.37 crore in the quarter ended March 2022 as against net profit of Rs 9.70 crore during the previous quarter ended March 2021. Sales declined 0.98% to Rs 98.32 crore in the quarter ended March 2022 as against Rs 99.29 crore during the previous quarter ended March 2021.For the full year,net loss reported to Rs 3.72 crore in the year ended March 2022 as against net profit of Rs 20.90 crore during the previous year ended March 2021. Sales rose 4.86% to Rs 399.87 crore in the year ended March 2022 as against Rs 381.35 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales98.3299.29 -1 399.87381.35 5 OPM %5.7215.38 -6.787.03 - PBDT19.6024.82 -21 55.4752.20 6 PBT18.2921.90 -16 45.8240.04 14 NP-23.379.70 PL -3.7220.90 PL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
